Please assess the completion status of the following clinical trial:

Trial Title: Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria: Patients on the postpartum ward at University Hospital will be offered inclusion in the study if they are:~* healthy,~* 18-40 years old,~* delivered a healthy term infant,~* intend to breastfeed,~* desire Implanon as their method of contraception, and~* agree to be randomized to early versus standard postpartum insertion.~Exclusion Criteria:~* obstetric complications including anemia with hematocrit\<30,~* transfusion,~* infection,~* severe pregnancy induced hypertension,~* prolonged hospitalization,~* coagulopathy,~* liver disease,~* undiagnosed genital bleeding,~* or other relative contraindication to Implanon® insertion (known or suspected pregnancy, known, suspected, or history of breast cancer, or hypersensitivity to any of the components in Implanon®).~* Women taking drugs that are potent inducers of hepatic enzymes will also be excluded, including barbiturates, griseofulvin, rifampin, phenylbutazone, phenytoin, carbamazepine, felbamate, oxcarbazepine, topiramate, modafinil, protease inhibitors, and herbal products including St. John's Wort.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Early postpartum insertion
- 2 (Type: ACTIVE_COMPARATOR): Standard postpartum insertion

Based on this trial design, predict the completion outcome and termination type (if applicable).